Kenvue Inc. is a consumer health company globally.
| Revenue (TTM) | $15.12B |
| Gross Profit (TTM) | $8.83B |
| EBITDA | $3.24B |
| Operating Margin | 17.80% |
| Return on Equity | 14.40% |
| Return on Assets | 6.61% |
| Revenue/Share (TTM) | $7.89 |
| Book Value | $5.62 |
| Price-to-Book | 3.13 |
| Price-to-Sales (TTM) | 2.22 |
| EV/Revenue | 2.728 |
| EV/EBITDA | 13.81 |
| Quarterly Earnings Growth (YoY) | 11.20% |
| Quarterly Revenue Growth (YoY) | 3.20% |
| Shares Outstanding | $1.92B |
| Float | $1.91B |
| % Insiders | 0.05% |
| % Institutions | 96.18% |
Volatility is currently contracting